Clarus Therapeutics Holdings Inc

Clarus Therapeutics Holdings Inc

CRXT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$434.81K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Clarus Therapeutics Holdings IncClarus Therapeutics Holdings Inc0-449%--3.3

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$434,808.00
Enterprise Value$24.75 Million
Earnings per Share$-2.35
Beta0
Outstanding Shares9,153,848

Return

Return on Equity448.76%ROE
Return on Assets-119.78%
Return on Invested Capital256.98%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales0.02Price to Sales
Price to Book Ratio-0.02Price to Book Ratio
Enterprise Value to Revenue1.29
Enterprise Value to EBIT-0.75
Enterprise Value to Net Income-1
Total Debt to Enterprise1.76
Debt to Equity-3.33Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Clarus Therapeutics Holdings Inc

2 employees

Clarus Therapeutics Holdings Insider Information FAQ

In the latest 13F quarter on Stockcircle, 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.